European Pharmaceutical Review

OCTOBER 9, 2022

Research published in the journal Nature Chemistry , shows how researchers from Stanford University in the US uncovered a promising new method to synthetically manufacture the compound tigilanol tiglate, named EBC-46, which could offer targeted medicine for cancer and other diseases. Natural sources of the compound can only be found in a small section of the Northeastern Australia rainforest, in fruit seeds from the blushwood tree ( Fontainea picrosperma ).

Food and Drug Administration 144

Food and Drug Administration Medicine Food Pharmaceutical 144

MedCity News

OCTOBER 14, 2022

Moving to value-based care models isn’t easy. But payers may be in the best position to make this change, according to the Business Group on Health. Employers, meanwhile, can encourage their employees to receive care from providers participating in value-based care.

140

140

pharmaphorum

OCTOBER 14, 2022

A consortium of industry and academic groups – led by Johnson & Johnson’s pharma division Janssen – has been set up to tackle the environmental impact of digital health products, specifically aimed at minimising waste that could end up in landfill. The Digital Health in a Circular Economy (DiCE) group was formed earlier this year with the aim of developing ways to “design, collect, directly reuse, refurbish, remanufacture, and recycle digital health devices.” The programme

Leads 124

Leads Electronics Ethics Healthcare 124

PharmaTimes

OCTOBER 14, 2022

Research has demonstrated a strong safety prolife and reduced tics among participants

Recruitment 124

Recruitment Safety Patients 124

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

European Pharmaceutical Review

OCTOBER 13, 2022

Scientists at MIT have demonstrated that a novel robotic capsule could potentially replace conventional biologic injection methods by tunnelling through the intestinal mucus barrier to deliver insulin. The research, published in the journal Science Robotics described how the new drug delivery system can transport large protein and small-molecule drugs, like vancomycin, an antibiotic peptide.

Transportation 137

Transportation Engineering Leads Medical 137

MedCity News

OCTOBER 11, 2022

In response to emailed questions, executives from Biofourmis, Force Therapeutics and Project Ronin shared products they’re developing in remote patient monitoring as part of the broader hospital at home trend.

Patients 131

Patients 131

PharmaTimes

OCTOBER 14, 2022

Therapy involves patients with colorectal cancer at 20 medical centres

Patients 119

Patients Medical 119

European Pharmaceutical Review

OCTOBER 14, 2022

RemeGen has announced that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) for its proprietary novel fusion protein Telitacicept (RC18) for the treatment of myasthenia gravis (MG). Telitacicept is a proprietary novel fusion protein from RemeGen to treat autoimmune diseases. It is constructed with the extracellular domain of the human transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI) receptor and the fragment crystallisable

Food and Drug Administration 124

Food and Drug Administration Side effects FDA Food 124

MedCity News

OCTOBER 11, 2022

Cybercriminals are weaponizing the same tools that healthcare providers use to operate and maintain secure IT systems, HHS warned in a recent report. Providers can protect themselves by having a firm grasp of what their IT environment looks like, as this may help them spot any suspicious security tool commands.

Healthcare Provider 131

Healthcare Provider Healthcare Healthcare 131

Pharmaceutical Technology

OCTOBER 14, 2022

German pharmaceutical firm Merck has extended its partnership with Moderna to jointly develop and sell mRNA-4157/V940, an investigational personalised cancer vaccine (PCV). In 2016, the companies entered a strategic partnership to develop novel messenger RNA (mRNA) based PCVs. They subsequently expanded the collaboration to include the development of antigen mRNA cancer vaccines in 2018.

Pharmaceutical 115

Pharmaceutical Management Patients Medical 115

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

PharmaTimes

OCTOBER 11, 2022

Therapy demonstrates significantly accelerated insulin absorption and early exposure

119

119

pharmaphorum

OCTOBER 11, 2022

An intranasal formulation of AstraZeneca’s widely-used COVID-19 vaccine Vaxzevria has failed at the first hurdle, after results from a phase 1 trial found it was unable to stimulate a strong immune response to the virus. The 30-subject study – funded by AZ and published in the Lancet journal eBioMedicine – tested two strengths of the current formulation of the vaccine administered as a nasal spray, with half the group receiving a second intranasal dose 28 days later, and half getting a reg

Patients 116

Patients 116

MedCity News

OCTOBER 13, 2022

While much of the world was quarantining and working from home during the Covid-19 pandemic, […].

Healthcare 130

Healthcare Healthcare 130

Medgadget

OCTOBER 11, 2022

Researchers at the University of California San Francisco have developed a suite of video games that have been designed to improve cognition in older adults who are otherwise healthy. The games aim to recreate common activities, such as banging a drum or driving a car. They also include a sophisticated algorithm that automatically adjusts the game difficulty depending on how well someone is playing, helping to stop less skilled players from becoming overwhelmed and more skilled players from beco

Training 115

Training Medicine 115

Advertisement

PharmaVoice

OCTOBER 10, 2022

Companies like Pfizer, Novartis, Sanofi and BMS are diving into the world of digital therapeutics while recognizing the limitations of the young field.

Pharma 116

Pharma 116

PharmaTimes

OCTOBER 13, 2022

Agreement will be key to building a pan-European market access practice

Marketing 114

Marketing 114

MedCity News

OCTOBER 11, 2022

How do organizations optimize and scale business intelligence? Here are five basic steps to consider when developing dashboards to assess your operational, financial and quality components within the care at home industry.

Management 128

Management 128

Medgadget

OCTOBER 11, 2022

At Johns Hopkins, clinical researchers have developed a set of surgical tools that allow them to more easily create a replacement ear for those born with malformed or missing ears. Currently, using cartilage harvested from the ribs, surgeons can create a new ear, but the process is difficult and requires some artistic talent to sculpt the cartilage into the right shape.

Medicine 115

Medicine Patients 115

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Safety

pharmaphorum

OCTOBER 12, 2022

It’s no secret that the healthcare system is made up of a panoply of diverse stakeholders, each with their own priorities, incentives, and motivations. Bringing those stakeholders together is an oft-lauded goal, but it’s proved easier said than done. The Eureka Institute, a Syracuse, Italy-based non-profit, is focused on addressing this disparity by providing education, research, and advocacy around the field of translational medicine.

Medicine 111

Medicine Training Education Healthcare 111

PharmaTimes

OCTOBER 11, 2022

Data from the study shows that ACD856 has a potential neuroprotective effect in a cellular mode

112

112

MedCity News

OCTOBER 14, 2022

Odyssey Therapeutics raised $168 million in Series B financing, the largest round of funding for a biotech startup this week. Companies developing new technologies in genetic diseases, cancer, and drug research are represented also represented in this week’s recap of life science financings.

Biopharma 128

Biopharma Pharma 128

PharmaTech

OCTOBER 12, 2022

CBER maps modernization plan to handle surge in research and applications.

FDA 109

FDA 109

Advertisement

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

Sales

pharmaphorum

OCTOBER 10, 2022

For the 32 million individuals in the US with food allergies, more research into symptoms, causes, and treatments has been long sought after, but historically underfunded. The National Institutes of Health (NIH), which oversees disease research, has a total annual budget equivalent to $120 per person, with only $0.19 per person being spent on food allergy research.

Food 111

Food Marketing Healthcare Healthcare 111

PharmaTimes

OCTOBER 10, 2022

Partnership will evaluate AI-powered technology in lung cancer care

Government 110

Government 110

MedCity News

OCTOBER 13, 2022

Providence issued a response to a letter sent by Sen. Patty Murray of Washington, in which she demanded the health system answer questions about its alleged efforts to aggressively bill patients who qualified for free or discounted care. The response denied that Providence aggressively pursued its poorest patients for medical debt, asserting that its “commitment to those in need has never been stronger.”.

Medical 126

Medical Patients Healthcare Healthcare 126

PharmaVoice

OCTOBER 12, 2022

As the Healthcare Businesswomen’s Association’s first chief people and DEI officer, Jones is poised to tackle pay gap inequity, systemic gender bias and leadership barriers impeding women of color.

Healthcare 105

Healthcare Healthcare 105

Advertiser: ZoomInfo

Marketing technology is essential for B2B marketers to stay competitive in a rapidly changing digital landscape — and with 53% of marketers experiencing legacy technology issues and limitations, they’re researching innovations to expand and refine their technology stacks. To help practitioners keep up with the rapidly evolving martech landscape, this special report will discuss: How practitioners are integrating technologies and systems to encourage information-sharing between departments and pr

Competition

European Pharmaceutical Review

OCTOBER 10, 2022

The US Food and Drug Administration (FDA) has approved GlaxoSmithKline Biologicals’ Boostrix vaccine for use in pregnant woman in their third trimester, to prevent against whooping cough (pertussis) in infants up to two months of age. Boostrix (Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed [Tdap]) boosts antibodies in individuals administered with the vaccine, which are then transferred to the growing foetus.

FDA 105

FDA Food and Drug Administration Side effects Food 105

PharmaTimes

OCTOBER 13, 2022

Virus can be lethal to humans and its spread is likely to accelerate this winter

109

109

MedCity News

OCTOBER 14, 2022

A nationwide railroad strike could be coming mid-November. There are some key considerations that healthcare providers should take note of while they anticipate the possibility of a this strike, including having proactive conversations with their suppliers and identifying product alternatives.

Healthcare Provider 126

Healthcare Provider Healthcare Healthcare 126

pharmaphorum

OCTOBER 14, 2022

Biotech company Odyssey Therapeutics, Inc. has announced a $168 million Series B financing, led by global venture capital firm General Catalyst, an active investor in the healthcare sector. The proceeds are to advance Odyssey’s precision immunomodulator and oncology medicine portfolio. The latest funding announcement follows the company’s $218 million Series A financing in December 2021 and brings the total capital raised to $386 million – enabling continuance of Odyssey’s mission to devel

Engineering 105

Engineering Medicine Electronics Healthcare 105

Advertisement

Distribution